BACKGROUND: The current resistance pattern of GABHS (group-A beta-hemolytic streptococci) in India has not been discussed. AIM: To fill the above-mentioned void, we planned this study to determine the prevalence and degree of antibacterial resistance in GABHS isolates. SETTINGS AND DESIGN: Children with acute pharyngo-tonsillitis who had not received antibiotic in the preceding week, attending the pediatric OPD, were prospectively enrolled over a period of 1 year. Throat swabs were collected from each child and transported to microbiology laboratory, as early as possible. MATERIALS AND METHODS: A throat swab culture for GABHS was done. All GABHS were subjected to antibiotic susceptibility and minimum inhibitory concentration (MIC) test according to Clinical Laboratory Standard Institute (CLSI) guidelines. RESULTS: In the present study, 12.6% (55/435) of the children with acute pharyngo-tonsillitis had throat swab culture positive for GABHS. The prevalence of macrolide resistance was 10.2%. The MIC50 for macrolide-resistant strain was 0.5 microg/mL (range, 0.125-8 microg/mL), and MIC90 was 8 microg/mL (range, 0.125-8 microg/mL). Tetracycline and co-trimoxazole resistances were 24.5% and 12.2% respectively. The values of MIC50 for tetracycline- and co-trimoxazole-resistant strains were 4 microg/mL (range, 0.125-32 microg/mL) and 2 microg/mL (range, 0.25-8 microg/mL) respectively. All isolates were sensitive to penicillin G and chloramphenicol on disc diffusion test. However, their MIC50 was 0.032 microg/mL (range, 0.012-0.125 microg/mL) and 2 microg/mL (range, 0.25-4 microg/mL) respectively. CONCLUSION: High prevalence of antimicrobial resistance found among GABHS needs a longitudinal surveillance of isolates from different centers in India.
BACKGROUND: The current resistance pattern of GABHS (group-A beta-hemolytic streptococci) in India has not been discussed. AIM: To fill the above-mentioned void, we planned this study to determine the prevalence and degree of antibacterial resistance in GABHS isolates. SETTINGS AND DESIGN: Children with acute pharyngo-tonsillitis who had not received antibiotic in the preceding week, attending the pediatric OPD, were prospectively enrolled over a period of 1 year. Throat swabs were collected from each child and transported to microbiology laboratory, as early as possible. MATERIALS AND METHODS: A throat swab culture for GABHS was done. All GABHS were subjected to antibiotic susceptibility and minimum inhibitory concentration (MIC) test according to Clinical Laboratory Standard Institute (CLSI) guidelines. RESULTS: In the present study, 12.6% (55/435) of the children with acute pharyngo-tonsillitis had throat swab culture positive for GABHS. The prevalence of macrolide resistance was 10.2%. The MIC50 for macrolide-resistant strain was 0.5 microg/mL (range, 0.125-8 microg/mL), and MIC90 was 8 microg/mL (range, 0.125-8 microg/mL). Tetracycline and co-trimoxazole resistances were 24.5% and 12.2% respectively. The values of MIC50 for tetracycline- and co-trimoxazole-resistant strains were 4 microg/mL (range, 0.125-32 microg/mL) and 2 microg/mL (range, 0.25-8 microg/mL) respectively. All isolates were sensitive to penicillin G and chloramphenicol on disc diffusion test. However, their MIC50 was 0.032 microg/mL (range, 0.012-0.125 microg/mL) and 2 microg/mL (range, 0.25-4 microg/mL) respectively. CONCLUSION: High prevalence of antimicrobial resistance found among GABHS needs a longitudinal surveillance of isolates from different centers in India.
Authors: René Bergmann; Mark van der Linden; Gursharan S Chhatwal; D Patric Nitsche-Schmitz Journal: Antimicrob Agents Chemother Date: 2014-02-03 Impact factor: 5.191
Authors: Nirmal K Ganguly; N K Arora; Sujith J Chandy; Mohamed Nadeem Fairoze; J P S Gill; Usha Gupta; Shah Hossain; Sadhna Joglekar; P C Joshi; Manish Kakkar; Anita Kotwani; Ashok Rattan; H Sudarshan; Kurien Thomas; Chand Wattal; Alice Easton; Ramanan Laxminarayan Journal: Indian J Med Res Date: 2011-09 Impact factor: 2.375
Authors: Asha C Bowen; Jonathan R Carapetis; Bart J Currie; Vance Fowler; Henry F Chambers; Steven Y C Tong Journal: Open Forum Infect Dis Date: 2017-11-02 Impact factor: 3.835
Authors: Nidhi Bhardwaj; Purva Mathur; Bijayini Behera; Kushal Mathur; Arti Kapil; Mahesh C Misra Journal: Indian J Med Res Date: 2018-01 Impact factor: 2.375
Authors: Shereen Mohamed Abd El-Ghany; Abeer Ahmed Abdelmaksoud; Sally Mohamed Saber; Dalia Hosni Abd El Hamid Journal: Ann Saudi Med Date: 2015 Sep-Oct Impact factor: 1.526